Progenics Pharmaceuticals, Inc. is now a
subsidiary of Lantheus Holdings, Inc.
Investors Investors

Investor Relations

Investor Relations

Progenics is proud to have joined the Lantheus family. Lantheus, a global leader in the field of medical imaging, develops, manufactures and commercializes essential diagnostic imaging agents and products that help healthcare professionals identify disease and improve patient treatment and care. These pioneering products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging. We are pleased to add three commercial products and a pipeline of therapeutic agents and PSMA-targeted imaging agents to the Lantheus portfolio. To learn more about investor relations, please click here.